530317 Stock Overview
Manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Godavari Drugs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹117.40 |
| 52 Week High | ₹155.00 |
| 52 Week Low | ₹86.99 |
| Beta | 0.89 |
| 11 Month Change | 2.09% |
| 3 Month Change | -7.78% |
| 1 Year Change | 19.16% |
| 33 Year Change | 114.23% |
| 5 Year Change | 633.75% |
| Change since IPO | 3,749.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| 530317 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 1.7% | 0.5% | 0.5% |
| 1Y | 19.2% | 42.5% | 27.5% |
Return vs Industry: 530317 underperformed the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 530317 underperformed the Indian Market which returned 27.5% over the past year.
Price Volatility
| 530317 volatility | |
|---|---|
| 530317 Average Weekly Movement | 9.4% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 530317's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 530317's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 111 | Mukund Kakani | godavaridrugs.com |
Godavari Drugs Limited manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan license and contract manufacturing services for API’s and drug intermediates.
Godavari Drugs Limited Fundamentals Summary
| 530317 fundamental statistics | |
|---|---|
| Market cap | ₹862.24m |
| Earnings (TTM) | ₹66.02m |
| Revenue (TTM) | ₹1.40b |
13.4x
P/E Ratio0.6x
P/S RatioIs 530317 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 530317 income statement (TTM) | |
|---|---|
| Revenue | ₹1.40b |
| Cost of Revenue | ₹1.04b |
| Gross Profit | ₹360.26m |
| Other Expenses | ₹294.24m |
| Earnings | ₹66.02m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.77 |
| Gross Margin | 25.67% |
| Net Profit Margin | 4.70% |
| Debt/Equity Ratio | 141.1% |
How did 530317 perform over the long term?
See historical performance and comparison